234 related articles for article (PubMed ID: 22855807)
1. Strain background influences neurotoxicity and behavioral abnormalities in mice expressing the tetracycline transactivator.
Han HJ; Allen CC; Buchovecky CM; Yetman MJ; Born HA; Marin MA; Rodgers SP; Song BJ; Lu HC; Justice MJ; Probst FJ; Jankowsky JL
J Neurosci; 2012 Aug; 32(31):10574-86. PubMed ID: 22855807
[TBL] [Abstract][Full Text] [Related]
2. Decreased locomotor activity in mice expressing tTA under control of the CaMKII alpha promoter.
McKinney BC; Schneider JS; Schafer GL; Lowing JL; Mohan S; Zhao MX; Heng MY; Albin RL; Seasholtz AF; Akil H; Murphy GG
Genes Brain Behav; 2008 Mar; 7(2):203-13. PubMed ID: 17640289
[TBL] [Abstract][Full Text] [Related]
3. Differential Neurotoxicity Related to Tetracycline Transactivator and TDP-43 Expression in Conditional TDP-43 Mouse Model of Frontotemporal Lobar Degeneration.
Kukreja L; Shahidehpour R; Kim G; Keegan J; Sadleir KR; Russell T; Csernansky J; Mesulam M; Vassar RJ; Wang L; Dong H; Geula C
J Neurosci; 2018 Jul; 38(27):6045-6062. PubMed ID: 29807909
[TBL] [Abstract][Full Text] [Related]
4. Sex-related dimorphism in dentate gyrus atrophy and behavioral phenotypes in an inducible tTa:APPsi transgenic model of Alzheimer's disease.
Melnikova T; Park D; Becker L; Lee D; Cho E; Sayyida N; Tian J; Bandeen-Roche K; Borchelt DR; Savonenko AV
Neurobiol Dis; 2016 Dec; 96():171-185. PubMed ID: 27569580
[TBL] [Abstract][Full Text] [Related]
5. Corticotrophin releasing factor accelerates neuropathology and cognitive decline in a mouse model of Alzheimer's disease.
Dong H; Murphy KM; Meng L; Montalvo-Ortiz J; Zeng Z; Kolber BJ; Zhang S; Muglia LJ; Csernansky JG
J Alzheimers Dis; 2012; 28(3):579-92. PubMed ID: 22045495
[TBL] [Abstract][Full Text] [Related]
6. Transgene expression in the Nop-tTA driver line is not inherently restricted to the entorhinal cortex.
Yetman MJ; Lillehaug S; Bjaalie JG; Leergaard TB; Jankowsky JL
Brain Struct Funct; 2016 May; 221(4):2231-49. PubMed ID: 25869275
[TBL] [Abstract][Full Text] [Related]
7. Effects of mouse strain, position of integration and tetracycline analogue on the tetracycline conditional system in transgenic mice.
Robertson A; Perea J; Tolmachova T; Thomas PK; Huxley C
Gene; 2002 Jan; 282(1-2):65-74. PubMed ID: 11814678
[TBL] [Abstract][Full Text] [Related]
8. Effects of the genetic background on cognitive performances of TG2576 mice.
Lassalle JM; Halley H; Daumas S; Verret L; Francés B
Behav Brain Res; 2008 Aug; 191(1):104-10. PubMed ID: 18433892
[TBL] [Abstract][Full Text] [Related]
9. Cardiac transgenesis with the tetracycline transactivator changes myocardial function and gene expression.
McCloskey DT; Turnbull L; Swigart PM; Zambon AC; Turcato S; Joho S; Grossman W; Conklin BR; Simpson PC; Baker AJ
Physiol Genomics; 2005 Jun; 22(1):118-26. PubMed ID: 15797971
[TBL] [Abstract][Full Text] [Related]
10. Developing tTA transgenic rats for inducible and reversible gene expression.
Zhou H; Huang C; Yang M; Landel CP; Xia PY; Liu YJ; Xia XG
Int J Biol Sci; 2009; 5(2):171-81. PubMed ID: 19214245
[TBL] [Abstract][Full Text] [Related]
11. Sustained preconditioning induced by cardiac transgenesis with the tetracycline transactivator.
Turnbull L; Zhou HZ; Swigart PM; Turcato S; Karliner JS; Conklin BR; Simpson PC; Baker AJ
Am J Physiol Heart Circ Physiol; 2006 Mar; 290(3):H1103-9. PubMed ID: 16243914
[TBL] [Abstract][Full Text] [Related]
12. Hippocampal adaptive response following extensive neuronal loss in an inducible transgenic mouse model.
Myczek K; Yeung ST; Castello N; Baglietto-Vargas D; LaFerla FM
PLoS One; 2014; 9(9):e106009. PubMed ID: 25184527
[TBL] [Abstract][Full Text] [Related]
13. Expression of the reverse tetracycline-transactivator gene causes emphysema-like changes in mice.
Sisson TH; Hansen JM; Shah M; Hanson KE; Du M; Ling T; Simon RH; Christensen PJ
Am J Respir Cell Mol Biol; 2006 May; 34(5):552-60. PubMed ID: 16415250
[TBL] [Abstract][Full Text] [Related]
14. The Tetracycline-Controlled Transactivator (Tet-On/Off) System in β-Cells Reduces Insulin Expression and Secretion in Mice.
Jouvet N; Bouyakdan K; Campbell SA; Baldwin C; Townsend SE; Gannon MA; Poitout V; Alquier T; Estall JL
Diabetes; 2021 Dec; 70(12):2850-2859. PubMed ID: 34610983
[TBL] [Abstract][Full Text] [Related]
15. Silencing and un-silencing of tetracycline-controlled genes in neurons.
Zhu P; Aller MI; Baron U; Cambridge S; Bausen M; Herb J; Sawinski J; Cetin A; Osten P; Nelson ML; Kügler S; Seeburg PH; Sprengel R; Hasan MT
PLoS One; 2007 Jun; 2(6):e533. PubMed ID: 17579707
[TBL] [Abstract][Full Text] [Related]
16. Effect size of memory deficits in mice with adult-onset P301L tau expression.
Hunsberger HC; Rudy CC; Weitzner DS; Zhang C; Tosto DE; Knowlan K; Xu Y; Reed MN
Behav Brain Res; 2014 Oct; 272():181-95. PubMed ID: 25004446
[TBL] [Abstract][Full Text] [Related]
17. Cardiac-specific expression of the tetracycline transactivator confers increased heart function and survival following ischemia reperfusion injury.
Elsherif L; Wang X; Grachoff M; Wolska BM; Geenen DL; O'Bryan JP
PLoS One; 2012; 7(1):e30129. PubMed ID: 22272284
[TBL] [Abstract][Full Text] [Related]
18. Changes in presenilin 2-binding Wnt proteins, behavior, amyloid-beta 42, gamma-secretase activity, and testosterone sensitivity in transgenic mice coexpressing tetracycline-controlled transactivator and human mutant presenilin 2.
Hwang DY; Cho JS; Kim CK; Shim SB; Jee SW; Lee SH; Seo SJ; Choi SY; Kim YK
Neuromolecular Med; 2006; 8(3):415-32. PubMed ID: 16775391
[TBL] [Abstract][Full Text] [Related]
19. Doxycycline for transgene control disrupts gut microbiome diversity without compromising acute neuroinflammatory response.
Koller EJ; Wood CA; Lai Z; Borgenheimer E; Hoffman KL; Jankowsky JL
J Neuroinflammation; 2024 Jan; 21(1):11. PubMed ID: 38178148
[TBL] [Abstract][Full Text] [Related]
20. Fluorescent Calcium Indicator Protein Expression in the Brain Using Tetracycline-Responsive Transgenic Mice.
Heindorf M; Hasan MT
Cold Spring Harb Protoc; 2015 Jul; 2015(7):689-96. PubMed ID: 26134909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
